Respiratory infections are among the leading causes of illness and death in the elderly, driven by immune aging, chronic ...

The decision to end the programme comes 18 months after Genmab's former partner for the acasunlimab, BioNTech, pulled out of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. On the regional level, as the Human Development Index ...

Novel hybrid polymer nanocarriers enable effective vaccine delivery in the lungs and the targeted activation of immune cells.

CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells taken from only one person.

Pulmonary hypertension (PH) has a high mortality rate if untreated. Unfortunately, the disease is not consistently diagnosed or treated across the United States. To improve the diagnosis and care of ...

Dec 3 (Reuters) - Roivant (ROIV.O), opens new tab will discontinue the development of its drug for a rare lung disease after it failed to show treatment benefits in patients in a mid-stage trial.

Image of a lung lobe from a carcinogen-exposed mouse. Cells expressing the basal cell marker KRT5 have been fluorescently labelled and can be seen spreading throughout the bronchial tree The ‘cell of ...

A 60-year-old’s routine health screening revealed stage 1 lung cancer – a reminder that the disease can strike anyone, and ...